首页|中药苷类化合物防治骨不愈合作用机制研究进展

中药苷类化合物防治骨不愈合作用机制研究进展

扫码查看
中药苷类化合物治疗骨不愈合的机制主要包括促进成骨细胞分化、抑制破骨细胞生成、促进新生血管生成、抑制炎症反应等,能够通过多途径、多靶点和多效性的治疗策略,实现促进骨质生成与抑制骨质破坏等多重目标.但目前研究仍存在诸多不足,如机制研究不够深入、缺乏大规模临床试验、药物递送系统不完善、未充分考虑个体差异以及长期不良反应不明确等.今后,应深入探索其分子机制,开展临床试验验证疗效和安全性,改进药物递送系统,考虑个体化治疗,评估长期不良反应,并探索与其他治疗方法的联合应用,为临床治疗骨折不愈合开辟新的策略和视角.
Research Progress in the Mechanisms of Glycoside Compounds of Chinese Medicinals in the Prevention and Treatment of Bone Nonunion Bone
The mechanisms by which glycoside compounds of Chinese medicinals treat bone nonunion include promoting osteoblast dif-ferentiation,inhibiting osteoclast formation,enhancing angiogenesis,and reducing inflammatory responses,etc.These compounds achieve multiple therapeutic objectives through multi-pathway,multi-target,and multi-efficacy strategies to promote bone formation and inhibit bone destruction,etc.However,current research faces limitations,such as insufficient depth in mechanistic studies,lack of large-scale clinical trials,inadequate drug delivery systems,lack of consideration for individual variability,and unclear long-term side effects.Future studies should focus on in-depth exploration of molecular mechanisms,clinical trials to validate efficacy and safety,improvements in drug delivery systems,personalized treatments,evaluation of long-term side effects,and potential integration with other therapies.These efforts may open new strategies and perspectives for clinical treatment of bone nonunion.

glycoside compounds of Chinese medicinalsfracturebone nonunionosteoblast

张进学、申建军、沈尚中、张津、薛盛中、陈志伟、周文杰

展开 >

甘肃中医药大学,甘肃 兰州 730000

甘肃省中医院,甘肃 兰州 730050

中药苷类化合物 骨折 骨不愈合 成骨细胞

2024

河南中医
河南省中医药学会 河南中医学院

河南中医

影响因子:0.968
ISSN:1003-5028
年,卷(期):2024.44(12)